[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole
Objective The International Vitreomacular Traction Study (IVTS) Group was convened to
develop an optical coherence tomography (OCT)-based anatomic classification system for …
develop an optical coherence tomography (OCT)-based anatomic classification system for …
Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges
H Massa, SY Pipis, T Adewoyin, A Vergados… - Clinical …, 2019 - Taylor & Francis
Macular edema (ME) is the most common sight-threatening complication in uveitis. The
diagnostic and therapeutic management of the uveitic macular edema (UME) might be …
diagnostic and therapeutic management of the uveitic macular edema (UME) might be …
Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results
Purpose To evaluate the 2-year outcomes of uveitic macular edema. Design Longitudinal
follow-up of a randomized cohort. Participants At baseline, 148 eyes of 117 patients enrolled …
follow-up of a randomized cohort. Participants At baseline, 148 eyes of 117 patients enrolled …
Tocilizumab treatment for refractory uveitis-related cystoid macular edema
Background This retrospective study investigated the efficacy of tocilizumab (TCZ), a fully
humanized antibody that binds both to soluble and membrane bound IL-6 receptors, for the …
humanized antibody that binds both to soluble and membrane bound IL-6 receptors, for the …
Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial
DS Friedman, JT Holbrook, H Ansari, J Alexander… - Ophthalmology, 2013 - Elsevier
Objective To report the 2-year incidence of raised intraocular pressure (IOP) and
glaucomatous optic nerve damage in patients with uveitis randomized to either fluocinolone …
glaucomatous optic nerve damage in patients with uveitis randomized to either fluocinolone …
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema
Objective To evaluate agreement between fluorescein angiography (FA) and optical
coherence tomography (OCT) results for diagnosis of macular edema in patients with uveitis …
coherence tomography (OCT) results for diagnosis of macular edema in patients with uveitis …
[HTML][HTML] Biomarkers and surrogate endpoints in uveitis: the impact of quantitative imaging
Purpose: Uveitis is a major cause of sight loss across the world. The reliable assessment of
intraocular inflammation in uveitis ('disease activity') is essential in order to score disease …
intraocular inflammation in uveitis ('disease activity') is essential in order to score disease …
Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis
SRJ Taylor, A Banker, A Schlaen, C Couto, E Matthe… - Retina, 2013 - journals.lww.com
Purpose: To assess the outcomes of the intravitreal administration of methotrexate in uveitis.
Methods: Multicenter, retrospective interventional case series of patients with noninfectious …
Methods: Multicenter, retrospective interventional case series of patients with noninfectious …
Seven-year outcomes of uveitic macular edema: the multicenter uveitis steroid treatment trial and follow-up study results
Purpose To evaluate the long-term outcomes of uveitic macular edema (ME). Design
Longitudinal follow-up of a cohort of participants in a randomized clinical trial. Participants A …
Longitudinal follow-up of a cohort of participants in a randomized clinical trial. Participants A …